Frequency Therapeutics, Inc. FREQ
Set alert
0.30 0.00 0.00%
At close · Nov 3
0.28 Day range 0.32
52-week range unavailable
- Open
- 0.29
- Prev close
- 0.2996
- Mkt cap
- 10.94M
- Vol
- 309.16K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.28
- High
- 0.32
- Forward P/E
- -0.26
- Beta
- 0.00
- Short ratio
- 3.51
- Inst. own
- 14.12%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 14, 2023
- 50-d avg
- 0.350724
- 200-d avg
- 0.639007
- 1y target
- 0.50
Financial health
Altman Z-Score
-4.48 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.0×
FY 2017 5y median -0.0× FY 2025
P/S 0.4×
FY 2017 5y median 0.4× FY 2025
P/B 0.1×
FY 2017 5y median 0.0× FY 2025
P/FCF -0.0×
FY 2017 5y median -0.0× FY 2025
EV/EBITDA -0.2×
FY 2017 5y median -1.2× FY 2025
EV/Sales 3.8×
FY 2017 5y median 0.0× FY 2025
FCF Yield -2809.3%
FY 2017 5y median -44.8% FY 2025
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin -1906.4%
FY 2017 5y median -597.3% FY 2025
Net Margin -1834.5%
FY 2017 5y median -602.0% FY 2025
ROE -228.0%
FY 2017 5y median -52.1% FY 2025
ROIC -116.9%
FY 2017 5y median -47.6% FY 2025
ROA -103.3%
FY 2017 5y median -45.7% FY 2025
Growth (YoY)
Revenue 181.5%
FY 2017 FY 2025
Operating Income -32.6%
FY 2017 FY 2025
EPS (diluted) -33.2%
FY 2017 FY 2025
Free Cash Flow -1.4%
FY 2017 FY 2025
Financial Health
Current Ratio 6.9×
FY 2017 5y median 6.9× FY 2025
Quick Ratio 6.9×
FY 2017 5y median 6.9× FY 2025
Debt / Equity 0.8×
FY 2017 5y median 0.3× FY 2025
Net Debt / EBITDA -0.2×
FY 2017 5y median 0.0× FY 2025
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31